Trademark: 88628744
Status Date
Monday, June 12, 2023
Filing Date
Tuesday, September 24, 2019
Published for Opposition
Tuesday, March 17, 2020
Abandoned Date
Monday, June 12, 2023
5 Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, Amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, and infectious diseases in humans
Jun 12, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 12, 2023
Abandonment - No Use Statement Filed
Nov 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 17, 2022
Sou Extension 5 Granted
Nov 8, 2022
Sou Extension 5 Filed
Nov 17, 2022
Case Assigned To Intent To Use Paralegal
Nov 8, 2022
Sou Teas Extension Received
Feb 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2022
Sou Extension 4 Granted
Feb 3, 2022
Sou Extension 4 Filed
Feb 3, 2022
Sou Teas Extension Received
Sep 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2021
Sou Extension 3 Granted
Sep 17, 2021
Sou Extension 3 Filed
Sep 17, 2021
Sou Teas Extension Received
May 8, 2021
Notice Of Approval Of Extension Request E-Mailed
May 6, 2021
Sou Extension 2 Granted
May 6, 2021
Sou Extension 2 Filed
May 6, 2021
Sou Teas Extension Received
Oct 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 20, 2020
Sou Extension 1 Granted
Oct 20, 2020
Sou Extension 1 Filed
Oct 20, 2020
Sou Teas Extension Received
May 12, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 17, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 17, 2020
Published For Opposition
Feb 26, 2020
Notification Of Notice Of Publication E-Mailed
Feb 11, 2020
Assigned To Lie
Feb 7, 2020
Approved For Pub - Principal Register
Feb 7, 2020
Examiner's Amendment Entered
Feb 7, 2020
Notification Of Examiners Amendment E-Mailed
Feb 7, 2020
Examiners Amendment E-Mailed
Feb 7, 2020
Examiners Amendment -Written
Jan 7, 2020
Notification Of Non-Final Action E-Mailed
Jan 7, 2020
Non-Final Action E-Mailed
Jan 7, 2020
Non-Final Action Written
Dec 26, 2019
Assigned To Examiner
Sep 28, 2019
New Application Office Supplied Data Entered
Sep 27, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
